 |
Public
Meeting on Written Prescription Information for Patients
July 31, 2003
National Transportation Safety Board Boardroom and
Conference Center
429 L’Enfant Plaza, SW., Washington, DC 20594
FDA is holding a public meeting to discuss the current status of
the private sector's efforts to provide useful written prescription
drug information to consumers.
- Meeting Agenda (WORD)
- Statement
from FDA Commissioner Mark B. McClellan, M.D. on FDA Public
Meeting to Discuss Written Prescription Information for
Consumers
- Meeting Presentations
(Posted 8/4/2003)
- FDA
and Consumer Medication Information (CMI), Paul J.
Seligman, M.D., M.P.H, CDER and Thomas J. McGinnis, R.Ph.,
Office of the Commissioner, FDA
- Evaluation
of Written Prescription Information Provided in Community
Pharmacies: A National Study, Bonnie L. Svarstad, Ph.D.,
University of Wisconsin - Madison
- Keystone Action Plan
- Federal
Register Meeting Notice
Back to Patient Labeling and Risk
Communication
Date created: July 30, 2003; Last Updated: August 4, 2003 |
|
